Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Education

Pharmaceutical

Alimera Sciences

Russell Skibsted

Riz Siddiqi

Steve Gill

Kapil Kumar

Ben Flagler

Bryce Werner

Tom Sinnamon

Brittany Underhill

David Dyer

Deirdre O Reilly

David Gregory

Kotaro Sai

Diane Reeves

Sergei Donskihh

Catherine Griffiths

Christopher Visick

Larry Karner

Mike Padilla

Laura Cegala Sphr, Gphr

Steve Morris

Trey Kincaid

Bill Garner

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research

Teams at Alimera Sciences

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research